Final Programme - iuphar

FC05 Translational science in the metabolic syndrome:
Basic and clinical pharmacology
Supported by an unrestricted grant from Novo Nordisk A/S, Denmark
Leaders: Leif Groop, (Sweden), Henning Beck-Nielsen, (Denmark) &
Jan-Erik Henriksen, (Denmark)
FC05.4 Normalizing blood glucose in metabolic syndrome II: Glitazones and
metformin
Chairs: Philip Home, (UK) & Henning Beck-Nielsen, (Denmark)
14:30 - 14:55 FC05.4.1 The role of metformin and glitazones in the regulation on hepatic glucose metabolism
Michael Roden, (Germany)
14:55 - 15:20 FC05.4.2 Rosiglitazone: Lessons from the RECORD study
Philip Home, (UK)
15:20 - 15:45 FC05.4.3 Metformin: Lessons from UKPDS
Amanda Adler, (UK)
15:45 - 16:15 COFFEE BREAK
16:15 - 16:40 FC05.4.4 Translational science in metabolic syndrome – future directions
Henning Beck-Nielsen, (Denmark)
16:40 - 16:55 FC05.4.5 Free Communication Presentation:
PPAR γ agonist pioglitazone provides comparable renoprotection to an ACE inhibitor
against normotensive nondiabetic nephropathy in rat
Peter Ochodnicky, (Slovak Republic), J Klimas, L Mesarosova, P Krenek, J Kyselovic
16:55 - 17:10 FC05.4.6 Free Communication Presentation:
Zinc Transporter 3, a pharmacological target for the treatment of beta-cell failure?
Kamille Smidt, (Denmark), A Pedersen, B Brock, J Rungby
Tuesday 20 July ■ 14:30 - 17:15 ■ Auditorium 15 85